Edoardo Bianchini, Pietro Lombardo, Tracy Milane, Domiziana Rinaldi, Lanfranco De Carolis, Marika Alborghetti, Antonio Suppa, Marco Salvetti, Clint Hansen, Nicolas Vuillerme
{"title":"The impact of nocturnal hypokinesia on supervised and unsupervised mobility in people with Parkinson’s disease","authors":"Edoardo Bianchini, Pietro Lombardo, Tracy Milane, Domiziana Rinaldi, Lanfranco De Carolis, Marika Alborghetti, Antonio Suppa, Marco Salvetti, Clint Hansen, Nicolas Vuillerme","doi":"10.1038/s41531-026-01587-2","DOIUrl":null,"url":null,"abstract":"Nocturnal hypokinesia (NH) is a disabling and underrecognized symptom of Parkinson’s disease (PD), affecting nighttime movements and sleep quality. However, its impact on daytime mobility remains unclear. This study investigated supervised and unsupervised mobility in propensity score-matched mild-to-moderate PD patients with (PD NH + ) and without NH (PD NH − ). Eighty-eight participants (44 PD NH+ and 44 PD NH-) underwent clinical assessments, mobility tests (i.e., 20-m forward walking, instrumented Timed-Up-and-Go and 3-metre backward walking test), and 5-day monitoring of average daily steps (AvDS) through a commercial activity tracker (Garmin Vivosmart 4). PD NH+ demonstrated worse functional mobility, reduced turning velocity, slower backwards walking, and fewer AvDS than PD NH-. Furthermore, NH severity correlated negatively with most supervised measures and with AvDS. However, sensitivity analyses controlling for fear of falling attenuated group differences in supervised mobility to non-significance, suggesting a preliminary nature of these findings. The association between NH severity and daily step count showed greater robustness. These findings suggest that NH could be associated with impaired daytime mobility and worse motor function. These findings highlight the importance of targeted interventions to address both nocturnal and diurnal mobility impairments in PD.","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"15 1","pages":""},"PeriodicalIF":8.5000,"publicationDate":"2026-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Parkinson's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41531-026-01587-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Nocturnal hypokinesia (NH) is a disabling and underrecognized symptom of Parkinson’s disease (PD), affecting nighttime movements and sleep quality. However, its impact on daytime mobility remains unclear. This study investigated supervised and unsupervised mobility in propensity score-matched mild-to-moderate PD patients with (PD NH + ) and without NH (PD NH − ). Eighty-eight participants (44 PD NH+ and 44 PD NH-) underwent clinical assessments, mobility tests (i.e., 20-m forward walking, instrumented Timed-Up-and-Go and 3-metre backward walking test), and 5-day monitoring of average daily steps (AvDS) through a commercial activity tracker (Garmin Vivosmart 4). PD NH+ demonstrated worse functional mobility, reduced turning velocity, slower backwards walking, and fewer AvDS than PD NH-. Furthermore, NH severity correlated negatively with most supervised measures and with AvDS. However, sensitivity analyses controlling for fear of falling attenuated group differences in supervised mobility to non-significance, suggesting a preliminary nature of these findings. The association between NH severity and daily step count showed greater robustness. These findings suggest that NH could be associated with impaired daytime mobility and worse motor function. These findings highlight the importance of targeted interventions to address both nocturnal and diurnal mobility impairments in PD.
期刊介绍:
npj Parkinson's Disease is a comprehensive open access journal that covers a wide range of research areas related to Parkinson's disease. It publishes original studies in basic science, translational research, and clinical investigations. The journal is dedicated to advancing our understanding of Parkinson's disease by exploring various aspects such as anatomy, etiology, genetics, cellular and molecular physiology, neurophysiology, epidemiology, and therapeutic development. By providing free and immediate access to the scientific and Parkinson's disease community, npj Parkinson's Disease promotes collaboration and knowledge sharing among researchers and healthcare professionals.